Overcoming anoikis--pathways to anchorage-independent growth in cancer

Marta C Guadamillas1, Ana Cerezo, Miguel A Del Pozo

  • 1Integrin Signaling Laboratory, Department of Vascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029 Madrid, Spain.

Journal of Cell Science
|September 24, 2011
PubMed

Insights

Cells can evade anoikis (cell-detachment-induced apoptosis) to become anchorage-independent, a key step in cancer progression and metastasis. Understanding these survival mechanisms is crucial for developing new anti-cancer therapies.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Molecular Biology

Background:

  • Anoikis, or cell-detachment-induced apoptosis, eliminates misplaced cells.
  • Detached cells can overcome anoikis, becoming anchorage-independent, a hallmark of cancer.

Purpose of the Study:

  • To explore the mechanisms by which tumor cells overcome anoikis.
  • To understand the role of anoikis resistance in cancer progression and metastasis.

Main Methods:

  • Review of cellular mechanisms involved in anoikis resistance.
  • Analysis of adaptive cellular changes and survival pathways.
  • Investigation of autophagy and entosis in circumventing anoikis.

Main Results:

  • Tumor cells develop strategies to bypass anoikis, including adaptive changes and hyperactivation of survival pathways.
  • Autophagy and entosis contribute to anoikis evasion by inducing a dormant state.
  • Anoikis resistance enables tumor growth, invasion, and metastasis.

Conclusions:

  • Overcoming anoikis is a critical event in malignant transformation.
  • Understanding anoikis resistance mechanisms can lead to strategies to inhibit tumor progression and metastasis.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...